Evidence map›Paper›PMID 32194605›Full record

ArticleFrontiers in plant science2020

Expression of Heterologous

Young-Saeng Kim, Seong-Im Park, Jin-Ju Kim, Joseph S Boyd, Joris Beld, Arnaud Taton, Kyoung-In Lee, Il-Sup Kim, James W Golden, Ho-Sung Yoon

Abstract read
In one paragraph

Article in Frontiers in plant science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Young-Saeng KimResearch Institute for Dok-do and Ulleung-do, Kyungpook National University, Daegu, South Korea.
Seong-Im ParkSchool of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, South Korea.
Jin-Ju KimSchool of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, South Korea.
Joseph S BoydDivision of Biological Sciences, University of California, San Diego, La Jolla, CA, United States.
Joris BeldDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, PA, United States.
Arnaud TatonDivision of Biological Sciences, University of California, San Diego, La Jolla, CA, United States.
Kyoung-In LeeBiotechnology Industrialization Center, Dongshin University, Naju, South Korea.
Il-Sup KimAdvanced Bio Resource Research Center, Kyungpook National University, Daegu, South Korea.
James W GoldenDivision of Biological Sciences, University of California, San Diego, La Jolla, CA, United States.
Ho-Sung YoonSchool of Life Sciences, BK21 Plus KNU Creative BioResearch Group, Kyungpook National University, Daegu, South Korea.

Funding

Development of an efficient cyanobacterial platform for heterologous expression and biosynthetic interrogations of natural products.R01GM118815 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GERWICK, LENA, GERWICK, WILLIAM HENRY · 2017 to 2020
$1.2M
NIGMS NIH HHS R01 GM118815
6 · The paper itself

Abstract

An excess of reactive oxygen species (ROS) can cause severe oxidative damage to cellular components in photosynthetic cells. Antioxidant systems, such as the glutathione (GSH) pools, regulate redox status in cells to guard against such damage. Dehydroascorbate reductase (DHAR, EC 1.8.5.1) catalyzes the glutathione-dependent reduction of oxidized ascorbate (dehydroascorbate) and contains a redox active site and glutathione binding-site. The

Indexed as

antioxidant-related enzymesantioxidantscyanobacteriumdehydroascorbate reductaseoxidative stress

Identifiers

PMID32194605
PMCPMC7063034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.